Scientific Program

SELECT AND VIEW SESSIONS OF YOUR CHOICE  *Alphabetical

Deselect All
Search
EANF Session I Advanced Diagnostics Redefining Neurological Diseases
Room B
(Crystal 3, 2F)
  • Date & Time
    November 26 (Thursday), 09:00-09:55
  • Chair(s)
    Seung Hyun Kim (Hanyang University Hospital, Korea)
    Ritsuko Hanajima (Tottori University, Japan)
  • Speaker(s)
    09:00-09:15 Advanced Diagnostic Strategies for Alzheimer’s Disease: Multimodal Perspectives
    Young Noh (Gachon University Gil Medical Center, Korea)
    09:15-09:30 Vista of Small Vessel Disease in Taiwan: An Approach Strategy from the Clinical and Neuroimaging
    Yi-Chu Liao (Taipei Veterans General Hospital, Taiwan)
    09:30-09:45 Atypical Parkinson’s Syndrome: What is it?
    Shunsuke Kobayashi (Teikyo University, Japan)
    09:45-09:55 Q&A
EANF Session II Policy-driven, Intersectoral Approaches for Neurological Diseases
Room B
(Crystal 3, 2F)
  • Date & Time
    November 26 (Thursday), 09:55-10:50
  • Chair(s)
    Jiann-Shing Jeng (National Taiwan University Hospital, Taiwan)
    Keun Hwa Jung (Seoul National University Hospital, Korea)
  • Speaker(s)
    09:55-10:10 Development and Challenge of Brain Bank in Taiwan
    Chi-Chao Chao (National Taiwan University Hospital, Taiwan)
    10:10-10:25 How to Manage the Geographical Doctor Distribution in Japan
    Yuishin Izumi (Tokushima University, Japan)
    10:25-10:40 Evolving Stroke Network System in Korea
    Jihoon Kang (Seoul National University Bundang Hospital, Korea)
    10:40-10:50 Q&A
EANF Session III Therapeutic Frontiers and Rapid Translation
Room B
(Crystal 3, 2F)
  • Date & Time
    November 26 (Thursday), 11:05-12:00
  • Chair(s)
    Yoshikazu Ugawa (Fukushima Medical University, Japan)
    Shey-Lin Wu (Show Chwan Memorial Hospital and Chang Bing Show Chwan Memorial Hospital, Taiwan)
  • Speaker(s)
    11:05-11:20 Beyond Immunomodulation: Emerging Molecular Targets in CIDP and GBS
    Sonoko Misawa (Institute of Science Tokyo, Japan)
    11:20-11:35 Repurposing Antidiabetic Drugs for Parkinson's Disease: Evidence from DPP-4 Inhibition
    Seong Ho Jeong (Yongin Severance Hospital, Korea)
    11:35-11:50 Transcranial Ultrasound Stimulation for Parkinson’s Disease in Taiwan: From Thermal Ablation to Neuromodulation
    Rou-Shayn Chen (Chang Gung Memorial Hospital, Taiwan)
    11:50-12:00 Q&A
Luncheon Symposium 2
Room B
(Crystal 3, 2F)
  • Date & Time
    November 26 (Thursday), 12:00-13:00
  • Chair(s)
    Hae Ri Na (Bobath Memorial Hospital, Korea)
  • Speaker(s)
    12:00-12:30 From Amyloid Removal to Clinical Implementation
    Hyuk-je Lee (The Catholic University of Korea, Seoul ST. Mary’s Hospital, Korea)
    12:30-13:00 Two Years of Lecanemab in Korea: Real-World Questions from Clinical Practice
    Hee-Jin Kim (Samsung Medical Center, Korea)
Scientific Session 4 State-of-the-Art Neuromodulation: Concepts and Clinical Applications
Room B
(Crystal 3, 2F)
  • Date & Time
    November 26 (Thursday), 15:10-16:40
  • Chair(s)
    Byung-Jo Kim (Korea University Anam Hospital, Korea)
  • Speaker(s)
    15:10-15:40 Neuromodulation in Parkinson’s Disease: From Circuit Modulation to Personalized DBS
    Rou-Shayn Chen (Chang Gung Memorial Hospital, Taiwan)
    15:40-16:00 Non-invasive neuromodulation using transcranial inference stimulation (TIS)
    Hyuk-June Moon (Korea Institute of Science and Technology, Korea)
    16:00-16:20 Neuromodulation in Epilepsy: Network-Guided Personalized Application of Neuromodulation in Epilepsy
    Jung Bin Kim (Korea University Anam Hospital, Korea)
    16:20-16:40 Neuromodulation in Alzheimer’s Disease: Emerging Network-Based and Disease-Modifying Approaches
    Younghee Jung (Hallym University Sacred Heart Hospital, Korea)
Scientific Session 7 Emerging Concepts in Neuromuscular Diseases: From Treatable Conditions to Advanced Immunotherapy
Room B
(Crystal 3, 2F)
  • Date & Time
    November 27 (Friday), 10:30-12:00
  • Chair(s)
    Byung-Ok Choi (Samsung Medical Center, Korea)
    Yang Ki Minn (Hallym University Kangnam Sacred Heart Hospital, Korea)
  • Speaker(s)
    10:30-10:50 Peripheral Neuropathy: Clues to Treatable Causes - CIDP, vasculitic neuropathy, amyloidosis, paraneoplastic neuropathy
    Jee-Eun Kim (Soonchunhyang University Bucheon Hospital, Korea)
    10:50-11:10 Recognizing Treatable Genetic Neuromuscular Diseases - Pompe disease, spinal muscular atrophy, ATTR amyloidosis
    Hyung Jun Park (Gangnam Severance Hospital, Korea)
    11:10-11:30 Antibody-Based Classification of Neuromuscular Disorders - MG subtypes and autoimmune nodopathies
    Yoon-Ho Hong (SMG-SNU Boramae Medical Center, Korea)
    11:30-12:00 Immune Dysregulation in Myasthenia Gravis and Neuroimmune Disorders: Insights from Single-Cell and Systems Immunology
    Yoshiaki Yasumizu (Yale School of Medicine, Yale University, USA)
Luncheon Symposium 4
Room B
(Crystal 3, 2F)
  • Date & Time
    November 27 (Friday), 12:00-13:00
  • Chair(s)
    Kon Chu (Seoul National University Hospital, Korea)
  • Speaker(s)
    12:00-13:00 Brivaracetam: A Better Levetiracetam or Just Another SV2A Ligand?
    Dong Wook Kim (Konkuk University Medical Center, Korea)
Scientific Session 10 Comprehensive Management of Increased Intracranial Pressure
Room B
(Crystal 3, 2F)
  • Date & Time
    November 27 (Friday), 15:10-16:40
  • Chair(s)
    Jeong Wook Park (The Catholic University of Korea Uijeongbu St. Mary's Hospital, Korea)
    Sang-Bae Ko (Seoul National University Hospital, Korea)
  • Speaker(s)
    15:10-15:40 Physiology of ICP and Cerebral Autoregulation
    Sung-Ho Ahn (Pusan National University Yangsan Hospital, Korea)
    15:40-16:10 Stepwise Management of IICP
    Tae Jung Kim (Seoul National University Hospital, Korea)
    16:10-16:40 IICP Management: Clinical Challenges and Pitfalls
    Yasuhiro Kuroda (Kagawa University Hospital, Japan)